Kesimpta® Support Program - Nurse Education and Bloods Service • There has been a change in the vendor supporting this service. • Both patient support services are now supported by IQVIA Ireland. • To refer your patient, please email the Referral Form to IQVIA Ireland at Kesimpta@IQVIA.com Sharps Bin Service • The Sharps Bin Service continues to be supported by HealthBeacon. • The Smart Unit is no longer provided as an offering. • Standard yellow bin sharps service remains in place. • You or your patient can refer directly to HealthBeacon: 01 – 211 8371.

Minimising the impact to you and your patients is a key priority. The Novartis Medical Affairs Team is actively working to support this transition. Thank you for your patience. Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk profile of the medicinal product. All suspected adverse reactions should be reported to HPRA Pharmacovigilance at www.hpra.ie. Adverse events can also be reported to Novartis preferably at www.novartis.com/report, by emailing drugsafety.dublin@novartis.com or by calling (01) 2080 612.